Works by Ling-Long Tang


Results: 86
    1
    2
    3
    4

    Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy aloneIdentification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone

    Published in:
    2015
    By:
    • Yu-Pei Chen;
    • Wen-Na Zhang;
    • Ling-Long Tang;
    • Yan-Ping Mao;
    • Xu Liu;
    • Lei Chen;
    • Guan-Qun Zhou;
    • Hai-Qiang Mai;
    • Jian-Yong Shao;
    • Wei-Hua Jia;
    • Tie-Bang Kang;
    • Mu-Sheng Zeng;
    • Ying Sun;
    • Jun Ma;
    • Chen, Yu-Pei;
    • Zhang, Wen-Na;
    • Tang, Ling-Long;
    • Mao, Yan-Ping;
    • Liu, Xu;
    • Chen, Lei
    Publication type:
    journal article
    5

    Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 18, p. 1589, doi. 10.1001/jama.2025.1132
    By:
    • Liang, Ye-Lin;
    • Liu, Xu;
    • Shen, Liang-Fang;
    • Hu, Guang-Yuan;
    • Zou, Guo-Rong;
    • Zhang, Ning;
    • Chen, Chuan-Ben;
    • Chen, Xiao-Zhong;
    • Zhu, Xiao-Dong;
    • Yuan, Ya-Wei;
    • Yang, Kun-Yu;
    • Jin, Feng;
    • Hu, Wei-Han;
    • Xie, Fang-Yun;
    • Huang, Ying;
    • Han, Fei;
    • Tang, Ling-Long;
    • Mao, Yan-Ping;
    • Lu, Li-Xia;
    • Sun, Rui
    Publication type:
    Article
    6

    Tissue-resident microbiota signature in nasopharyngeal carcinoma.

    Published in:
    Microbiome, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40168-025-02114-w
    By:
    • Tan, Xi-Rong;
    • Qiao, Han;
    • Li, Ying-Qing;
    • Jiang, Wei;
    • Huang, Sheng-Yan;
    • Gong, Sha;
    • Li, Wen-Fei;
    • Tang, Ling-Long;
    • Zhou, Guan-Qun;
    • Liang, Ye-Lin;
    • Li, Hui;
    • He, Qing-Mei;
    • Bai, Jie-Wen;
    • Ye, Ming-Liang;
    • Wang, Jing-Yun;
    • Huang, Sai-Wei;
    • Li, Jun-Yan;
    • Gan, Chun-Qiao;
    • Li, Ying-Qin;
    • Zhao, Yin
    Publication type:
    Article
    7

    Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial.

    Published in:
    CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 3, p. 203, doi. 10.3322/caac.21881
    By:
    • Tang, Ling‐Long;
    • Chen, Lin;
    • Xu, Gui‐Qiong;
    • Zhang, Ning;
    • Huang, Cheng‐Long;
    • Li, Wen‐Fei;
    • Mao, Yan‐Ping;
    • Zhou, Guan‐Qun;
    • Lei, Feng;
    • Chen, Lu‐Si;
    • Huang, Shao Hui;
    • Chen, Lei;
    • Chen, Yu‐Pei;
    • Zhang, Yuan;
    • Liu, Xu;
    • Xu, Cheng;
    • Zhao, Yin;
    • Li, Ji‐Bin;
    • Liu, Na;
    • Xie, Fang‐Yun
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 12, p. 2230, doi. 10.1002/cncr.28049
    By:
    • Chen, Yong;
    • Sun, Ying;
    • Liang, Shao‐Bo;
    • Zong, Jing‐Feng;
    • Li, Wen‐Fei;
    • Chen, Mo;
    • Chen, Lei;
    • Mao, Yan‐Ping;
    • Tang, Ling‐Long;
    • Guo, Ying;
    • Lin, Ai‐Hua;
    • Liu, Meng‐Zhong;
    • Ma, Jun
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    49